InMed adds William J. Garner to its board of directors
Dr. Garner is the founder of EGB Advisors PR LLC, a pharmaceutical commercialization boutique, where he has focused on advancing technologies and companies to significant value inflection points, leading to monetization of assets via licensing, M&A or IPO transactions.
Dr. Garner has extensive director-level and executive management experience, including his current appointment as Chairman & Founder of Update Pharma and as a Director at IGXBio; previously serving as CEO of Invion Limited, a clinical-stage anti-inflammatory drug development company that resulted from the merger of a private company he founded; and as a co-founder and Director of Del Mar Pharmaceuticals.
Dr. Garner brings additional medical affairs experience from his tenure at Hoffmann LaRoche's oncology division.
Prior to Roche, Dr. Garner was a healthcare merchant banker in New York City.
He has a Master of Public Health from Harvard and earned his M.D. at New York Medical College. Dr. Garner did residency training in Anatomic Pathology at Columbia-Presbyterian and is currently a licensed physician in the State of New York.
InMed also announces it has accepted the resignation of Steve Tong as a Director of the Company. ■
LATEST MOVES FROM British Columbia
- Arak Resources appoints Jonathan Hykawy as director
- Arbutus Biopharma appoints Daniel Burgess as director
- International Lithium Corp. names CFO, announces further additions
- Asiamet Resources appoints Peter John Bird as CEO
- International Lithium Corp. names Maurice Brooks to board
More inside POST